Enucleation for Ocular Tumors
Many studies over the past decade report a trend toward fewer enucleations, suggesting that improved treatments prevent end-stage eye disease. Interestingly, however, the incidence of enucleation for neoplasia has not decreased despite the more widespread
- PDF / 26,573,707 Bytes
- 325 Pages / 504.63 x 737.01 pts Page_size
- 100 Downloads / 175 Views
123
Clinical Ophthalmic Oncology
Catherine J. Hwang Bhupendra C. K. Patel Arun D. Singh Editors
Clinical Ophthalmic Oncology Orbital Tumors Third Edition
Editors Catherine J. Hwang Division of Orbital and Oculofacial Plastic Surgery, Cole Eye Institute Cleveland Clinic Foundation Cleveland, OH USA
Bhupendra C. K. Patel Division of Facial Cosmetic and Reconstructive Surgery University of Utah Salt Lake City, UT USA
Arun D. Singh Department of Ophthalmic Oncology, Cole Eye Institute Cleveland, OH USA
ISBN 978-3-030-13557-7 ISBN 978-3-030-13558-4 (eBook) https://doi.org/10.1007/978-3-030-13558-4 © Springer Nature Switzerland AG 2019 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Springer imprint is published by the registered company Springer Nature Switzerland AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
Preface
Ophthalmic tumors are rare and diverse so their diagnosis can be quite complex. Treatment usually requires special expertise and equipment and in many instances is controversial. The field is advancing rapidly, because of accelerating progress in tumor biology, pharmacology, and instrumentation. Increasingly, the care of patients with an ocular or adnexal tumor is provided by a multidisciplinary team, consisting of ocular oncologists, general oncologists, radiotherapists, pathologists, psychologists, and other specialists. For all these reasons, we felt there was a need for the new edition of the textbook providing a balanced view of current clinical practice. Although each section of Clinical Ophthalmic Oncology now represents a standalone volume, each chapter has a similar layout with boxes that highlight the key features, tables that provide comparison, and flow diagrams that outline therapeutic approaches. We gratefully acknowledge the contributions of Julian Perry, MD, for editing the previo
